Paloma Partners’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-23,199
Closed -$4.17M 2530
2017
Q3
$4.17M Buy
23,199
+15,500
+201% +$2.16M 0.06% 343
2017
Q2
$798K Buy
+7,699
New +$628K 0.01% 1309

Paloma Partners's KITE Position: Q4 2017 in Review

Paloma Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 23,199 shares — an estimated $4.17M sold.

Paloma Partners first reported a position in KITE in Q2 2017 and held it in 2 quarters. The position peaked at $4.17M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Paloma Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Paloma Partners sold 23,199 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.17M.
  • Paloma Partners first reported a position in Kite Pharma, Inc. in Q2 2017 and held it in 2 quarters.
  • Paloma Partners's Kite Pharma, Inc. position peaked at $4.17M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Paloma Partners's 13F filing for Q4 2017, filed 14 Feb 2018.